Literature DB >> 18178960

Integration of clinical chemistry, expression, and metabolite data leads to better toxicological class separation.

Jeppe S Spicker1, Søren Brunak, Klaus S Frederiksen, Henrik Toft.   

Abstract

A large number of databases are currently being implemented within toxicology aiming to integrate diverse biological data, such as clinical chemistry, expression, and other types of data. However, for these endeavors to be successful, tools for integration, visualization, and interpretation are needed. This paper presents a method for data integration using a hierarchical model based on either principal component analysis or partial least squares discriminant analysis of clinical chemistry, expression, and nuclear magnetic resonance data using a toxicological study as case. The study includes the three toxicants alpha-naphthyl-isothiocyanate, dimethylnitrosamine, and N-methylformamide administered to rats. Improved predictive ability of the different classes is seen, suggesting that this approach is a suitable method for data integration and visualization of biological data. Furthermore, the method allows for correlation of biological parameters between the different data types, which could lead to an improvement in biological interpretation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178960     DOI: 10.1093/toxsci/kfn001

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  11 in total

1.  In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.

Authors:  Feng Cheng; Dan Theodorescu; Ira G Schulman; Jae K Lee
Journal:  J Theor Biol       Date:  2011-08-27       Impact factor: 2.691

2.  Towards enhanced and interpretable clustering/classification in integrative genomics.

Authors:  Yang Young Lu; Jinchi Lv; Jed A Fuhrman; Fengzhu Sun
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

Review 3.  Multi-omics integration in biomedical research - A metabolomics-centric review.

Authors:  Maria A Wörheide; Jan Krumsiek; Gabi Kastenmüller; Matthias Arnold
Journal:  Anal Chim Acta       Date:  2020-10-22       Impact factor: 6.558

4.  Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs.

Authors:  Suleiman A Khan; Ali Faisal; John Patrick Mpindi; Juuso A Parkkinen; Tuomo Kalliokoski; Antti Poso; Olli P Kallioniemi; Krister Wennerberg; Samuel Kaski
Journal:  BMC Bioinformatics       Date:  2012-05-30       Impact factor: 3.169

5.  Existence of inverted profile in chemically responsive molecular pathways in the zebrafish liver.

Authors:  Choong Yong Ung; Siew Hong Lam; Xun Zhang; Hu Li; Jing Ma; Louxin Zhang; Baowen Li; Zhiyuan Gong
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

6.  Integrative set enrichment testing for multiple omics platforms.

Authors:  Laila M Poisson; Jeremy M Taylor; Debashis Ghosh
Journal:  BMC Bioinformatics       Date:  2011-11-25       Impact factor: 3.169

7.  Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats.

Authors:  Sebastian Marciniak; Artur Wnorowski; Katarzyna Smolińska; Beata Walczyna; Waldemar Turski; Tomasz Kocki; Piotr Paluszkiewicz; Jolanta Parada-Turska
Journal:  Anal Cell Pathol (Amst)       Date:  2018-09-20       Impact factor: 2.916

Review 8.  Machine Learning and Integrative Analysis of Biomedical Big Data.

Authors:  Bilal Mirza; Wei Wang; Jie Wang; Howard Choi; Neo Christopher Chung; Peipei Ping
Journal:  Genes (Basel)       Date:  2019-01-28       Impact factor: 4.096

9.  Principal component analysis for designed experiments.

Authors:  Tomokazu Konishi
Journal:  BMC Bioinformatics       Date:  2015-12-09       Impact factor: 3.169

10.  Characterization of chemically induced liver injuries using gene co-expression modules.

Authors:  Gregory J Tawa; Mohamed Diwan M AbdulHameed; Xueping Yu; Kamal Kumar; Danielle L Ippolito; John A Lewis; Jonathan D Stallings; Anders Wallqvist
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.